Analytical method development refers to the systematic process of designing, optimizing, and validating analytical procedures used to assess a specific attribute of pharmaceutical substances and products. These methods are essential for identifying chemical composition, detecting impurities, and ensuring batch-to-batch consistency. The process involves selecting appropriate analytical techniques, such as chromatography, spectroscopy, or mass spectrometry, and tailoring them to the specific characteristics of the compound under investigation. The ultimate goal is to produce a robust, reproducible, and regulatory-compliant method that can be used throughout the product lifecycle. At our company, we provide comprehensive analytical method development services designed to support molecules from early discovery through commercialization. Our expertise spans small molecules, biologics, and advanced therapeutic modalities, ensuring that every analytical challenge is addressed with scientific rigor and regulatory compliance.
Why is Analytical Method Development Important?
Analytical method development plays a pivotal role in drug development for several reasons:
- Ensuring Product Quality and Safety: Accurate analytical methods are essential for confirming the identity, purity, stability, potency and shelf-life of a drug product. This ensures patient safety and therapeutic efficacy.
- Regulatory Compliance: Global regulatory authorities such as the FDA, EMA, and ICH require validated analytical methods as part of drug approval submissions. Poorly developed methods can delay approvals or lead to regulatory setbacks.
- Supporting Process Development: Analytical methods provide critical data that guide formulation development, process optimization, and scale-up activities.
- Cost and Time Efficiency: Robust analytical methods reduce variability, minimize rework, and accelerate timelines, ultimately saving both time and resources.
Our Capabilities
Our company offers a full spectrum of analytical method development services tailored to meet diverse client needs. Our multidisciplinary team of scientists leverages state-of-the-art instrumentation and deep industry experience to deliver high-quality, regulatory-compliant results. We can develop phase-appropriate, data-driven analytical strategies for:
Chromatographic and Spectroscopic Analysis
Physicochemical and Solid-State Characterization
Assay, Impurity, and Stability Testing
Formulation, Microbiological, and Process Support Testing
Bioanalytical and Biophysical Methods
- High-performance liquid chromatography (HPLC)
- Ultra-performance liquid chromatography (UPLC)
- Gas chromatography (GC)
- Ion chromatography (IC)
- Chiral chromatography
- LC-MS/MS, GC-MS, high-resolution mass spectrometry (HRMS)
- UV-visible spectroscopy
- Fourier transform infrared spectroscopy (FTIR)
- Nuclear magnetic resonance (NMR)
- ...
- Solubility and intrinsic dissolution
- pH, pKa, logP/logD
- Osmolality and viscosity
- Residual solvents and moisture content
- Thermal analysis (DSC, TGA)
- Particle size distribution
- X-ray Powder Diffraction (XRPD)
- Polymorph screening and crystallinity analysis
- Hygroscopicity testing
- Morphology and surface properties
- ...
- API assay and content uniformity
- Related substances and impurity profiling
- Degradation products analysis
- Elemental impurities
- Stability-indicating methods
- Forced degradation studies
- ICH stability studies (accelerated and long-term)
- Shelf-life
- ...
- Dissolution testing (USP I, II, III)
- Disintegration testing
- Drug release profiling
- Excipient compatibility studies
- Microbiological testing
- Biorelevant testing
- In-process control testing
- Cleaning validation testing
- Batch release testing
- ...
- Ligand-binding assays (ELISA, ECL)
- Cell-based potency assays
- Pharmacokinetic (PK) and pharmacodynamic (PD) studies
- Protein characterization (e.g., aggregation, charge variants)
- ...
Target Product / Molecule Type
Our analytical expertise spans a broad range of product types and molecular modalities, enabling us to support diverse pharmaceutical and biopharmaceutical pipelines. We provide services for:
Small Molecules
- Active pharmaceutical ingredients (APIs)
- Intermediates and impurities
- Solid oral dosage forms, injectables, topical formulations, etc.
Biologics and Advanced Modalities
- Proteins and monoclonal antibodies
- Peptides and oligonucleotides
- Cell and gene therapy products
- ...
Complex and Specialized Products
- Drug-device combinations
- Controlled-release formulations
- Inhalation and ophthalmic products
- ...
Our methods are designed to evaluate not only APIs but also excipients, raw materials, degradation products, and finished dosage forms.
How Do We Develop an Analytical Method
We follow a structured and science-driven approach to develop robust, reliable, and regulatory-compliant analytical methods:
- Define Analytical Objectives: Understand the analyte's properties and define the method purpose (e.g., assay, impurity, stability), along with regulatory requirements.
- Leverage Existing Knowledge: Review prior methods, scientific literature, pharmacopoeias, and regulatory guidelines to identify suitable starting points and reduce development time.
- Select Technique and Initial Conditions: Choose appropriate analytical techniques (e.g., HPLC, GC, LC-MS) and establish initial parameters such as column, detector, and mobile phase.
- Develop and Optimize the Method: Optimize key parameters to achieve adequate resolution, sensitivity, peak shape, and run time.
- Evaluate Method Performance: Conduct preliminary testing to assess retention, specificity, and separation from impurities or matrix components.
- Confirm Suitability and Robustness: Define system suitability criteria (e.g., resolution, tailing factor) and ensure the method is consistent and reliable under varied conditions.
- Validate and Transfer the Method: Validate the method according to ICH guidelines (accuracy, precision, linearity, LOD/LOQ, robustness) and transfer it to QC labs for routine use.
Analytical method development is a cornerstone of successful pharmaceutical development. It ensures that drug products meet stringent quality standards while supporting regulatory approval and commercialization. By combining advanced analytical technologies, broad molecule expertise, and a deep understanding of regulatory expectations, we deliver customized solutions that accelerate development timelines and reduce risk. Whether working with small molecules, biologics, or advanced therapies, our analytical services are designed to support your program from concept to commercialization with confidence and precision.
Please kindly note that our services are for research use only.
